1. Home
  2. AXTI vs SGMT Comparison

AXTI vs SGMT Comparison

Compare AXTI & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • SGMT
  • Stock Information
  • Founded
  • AXTI 1986
  • SGMT 2006
  • Country
  • AXTI United States
  • SGMT United States
  • Employees
  • AXTI N/A
  • SGMT N/A
  • Industry
  • AXTI Semiconductors
  • SGMT
  • Sector
  • AXTI Technology
  • SGMT
  • Exchange
  • AXTI Nasdaq
  • SGMT Nasdaq
  • Market Cap
  • AXTI 93.9M
  • SGMT 93.7M
  • IPO Year
  • AXTI 1998
  • SGMT 2023
  • Fundamental
  • Price
  • AXTI $1.97
  • SGMT $4.76
  • Analyst Decision
  • AXTI Strong Buy
  • SGMT Strong Buy
  • Analyst Count
  • AXTI 5
  • SGMT 5
  • Target Price
  • AXTI $5.30
  • SGMT $21.60
  • AVG Volume (30 Days)
  • AXTI 462.6K
  • SGMT 701.7K
  • Earning Date
  • AXTI 10-31-2024
  • SGMT 11-13-2024
  • Dividend Yield
  • AXTI N/A
  • SGMT N/A
  • EPS Growth
  • AXTI N/A
  • SGMT N/A
  • EPS
  • AXTI N/A
  • SGMT N/A
  • Revenue
  • AXTI $94,685,000.00
  • SGMT N/A
  • Revenue This Year
  • AXTI $32.13
  • SGMT N/A
  • Revenue Next Year
  • AXTI $12.84
  • SGMT N/A
  • P/E Ratio
  • AXTI N/A
  • SGMT N/A
  • Revenue Growth
  • AXTI 15.24
  • SGMT N/A
  • 52 Week Low
  • AXTI $1.73
  • SGMT $2.39
  • 52 Week High
  • AXTI $5.64
  • SGMT $20.71
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 41.90
  • SGMT 45.20
  • Support Level
  • AXTI $2.00
  • SGMT $4.19
  • Resistance Level
  • AXTI $2.23
  • SGMT $6.40
  • Average True Range (ATR)
  • AXTI 0.11
  • SGMT 0.50
  • MACD
  • AXTI -0.01
  • SGMT -0.20
  • Stochastic Oscillator
  • AXTI 48.00
  • SGMT 25.79

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single-element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

Share on Social Networks: